Xin Liu

Title: Innovations of Inventor Xin Liu

Introduction

Xin Liu is a prominent inventor based in Menlo Park, CA (US). She has made significant contributions to the field of biochemistry, particularly in the modulation of p300/CBP activity. With a total of 2 patents, her work has the potential to impact the treatment of various diseases and disorders.

Latest Patents

Xin Liu's latest patents focus on methods and compositions for modulating p300/CBP activity. The inventions relate to identifying compounds that can modulate the activity of p300/CBP. These compounds are designed or screened to bind to specific amino acid residues of the newly identified lysine-CoA inhibitor binding site, L1 loop, electronegative pocket, or electronegative groove of the HAT domain of p300/CBP. The patents also provide methods for producing a semi-synthetic HAT domain and compositions for preventing or treating diseases associated with p300/CBP.

Career Highlights

Throughout her career, Xin Liu has worked with esteemed institutions such as The Wistar Institute and Johns Hopkins University. Her research has garnered attention for its innovative approach to understanding and manipulating biochemical pathways.

Collaborations

Xin Liu has collaborated with notable scientists, including Ronen Marmorstein and Philip A. Cole. These collaborations have further enriched her research and contributed to advancements in her field.

Conclusion

Xin Liu's innovative work in modulating p300/CBP activity showcases her dedication to advancing biochemistry and medicine. Her contributions are paving the way for new therapeutic strategies and enhancing our understanding of complex biological processes.